Ishikura, Kenji
Omae, Kenji
Sasaki, Sho
Shibagaki, Yugo
Ichioka, Satoko
Okuda, Yusuke
Koitabashi, Kenichiro
Suyama, Koichi
Mizukami, Takuro
Kondoh, Chihiro
Hirata, Sumio
Matsubara, Takeshi http://orcid.org/0000-0002-2380-1551
Hoshino, Junichi
Yanagita, Motoko
Article History
Received: 22 May 2023
Accepted: 20 June 2023
First Online: 7 July 2023
Declarations
:
: Y.S has received honoraria from AstraZeneca, Kyowa Kirin Co., Ltd., and Otsuka Pharmaceutical Co., Ltd., and research fundings from Bayer AG, Baxter, Kyowa Kirin Co., Ltd., and Teijin. T. M has received a research funding from Eli Lilly Japan K.K. J.H has received honoraria from Kyowa Kirin Co., Ltd., Mitsubishi Tanabe Pharma, Ono Pharm, AstraZeneca and Astellas Pharma Inc, and a research grant from Otsuka Pharmaceutical Co., Ltd. M.Y has received honoraria from Astellas Pharma Inc, AstraZeneca, Kyowa Kirin Co., Ltd., Chugai-Pharmaceutical Co., Ltd., Bayer AG, and Mitsubishi Tanabe Pharma, and research grants from Mitsubishi Tanabe Pharma, Boehringer Ingelheim International GmbH, and scholarship donations from Kyowa Kirin Co., Ltd., Chugai-Pharmaceutical Co., Ltd., and Mitsubishi Tanabe Pharma. The other authors declare no potential conflicts of interest.